Apellis Announces Keli Walbert to Join the Board of Directors
WALTHAM, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that Keli Walbert will join the Apellis Board of Directors, effective immediately. Ms.
Global Biologics Market to Reach USD 1,077.2 Billion by 2035, Growing at a CAGR of 9.1% from 2025-2035 | Future Market Insights Inc.
Germany's biologics market, the largest in Europe, is expected to grow at a 3.8% CAGR from 2025 to 2035. AI is driving this growth by enhancing R&D, optimizing drug design, and identifying novel ...